A systematic review of worldwide incidence of nonmelanoma skin cancer

Clicks: 1
ID: 291307
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #168 of 304 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 304 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Background Nonmelanoma skin cancer (NMSC) is the most common cancer affecting white‐skinned individuals and the incidence is increasing worldwide. Objectives This systematic review brings together 75 studies conducted over the past half century to look at geographical variations and trends worldwide in NMSC, and specifically incidence data are compared with recent U.K. cancer registry data. Methods Following the development of a comprehensive search strategy, an assessment tool was adapted to look at the methodological quality of the eligible studies. Results Most of the studies focused on white populations in Europe, the U.S.A. and Australia; however, limited data were available for other skin types in regions such as Africa. Worldwide the incidence for NMSC varies widely with the highest rates in Australia [> 1000/100 000 person‐years for basal cell carcinoma (BCC)] and the lowest rates in parts of Africa (< 1/100 000 person‐years for BCC). The average incidence rates in England were 76·21/100 000 person‐years and 22·65/100 000 person‐years for BCC and squamous cell carcinoma (SCC), respectively, with highest rates in the South‐West of England (121·29/100 000 person‐years for BCC and 33·02/100 000 person‐years for SCC) and lowest rates by far in London (0·24/100 000 person‐years for BCC and 14·98/100 000 person‐years for SCC). The incidence rates in the U.K. appear to be increasing at a greater rate when compared with the rest of Europe. Conclusions NMSC is an increasing problem for health care services worldwide. This review highlights a requirement for prevention studies in this area and the issues surrounding incomplete NMSC registration. Registration standards of NMSC should be improved to the level of other invasive disease.
Reference Key
openalex_W1529230314 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Andrew Lomas, Jo Leonardi‐Bee, Fiona Bath‐Hextall
Journal the british journal of dermatology
Year 2012
DOI
10.1111/j.1365-2133.2012.10830.x
URL
https://doi.org/10.1111/j.1365-2133.2012.10830.x
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.